NDC 28595-310 – HISTEX-DM New Formulation
Dextromethorphan Hydrobromide 20 mg/5mL; Pseudoephedrine Hydrochloride 30 mg/5mL; Triprolidine Hydrochloride 2.5 mg/5mL · Syrup · Oral
Product NDC28595-310
Product details
- Brand name
- HISTEX-DM New Formulation
- Generic name
- DEXTROMETHORPHAN HBr, PSEUDOEPHEDRINE HCI, and TRIPROLIDINE HCI
- Labeler
- Allegis Pharmaceuticals, LLC
- Dosage form
- Syrup
- Route
- Oral
- Marketing category
- OTC MONOGRAPH DRUG · M012
- Marketed since
- March 10, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Sigma-1 Agonist; Uncompetitive N-methyl-D-aspartate Receptor Antagonist; alpha-Adrenergic Agonist
Active ingredients
- Dextromethorphan Hydrobromide 20 mg/5mL
- Pseudoephedrine Hydrochloride 30 mg/5mL
- Triprolidine Hydrochloride 2.5 mg/5mL
Uses, dosage, side effects and warnings for HISTEX-DM New Formulation →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 28595-310-16 | 473 mL in 1 BOTTLE (28595-310-16) | Mar 10, 2025 |